Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Language
Publication year range
1.
Biochemistry ; 63(9): 1178-1193, 2024 May 07.
Article in English | MEDLINE | ID: mdl-38669355

ABSTRACT

Herein, we present a novel esterase enzyme, Ade1, isolated from a metagenomic library of Amazonian dark earths soils, demonstrating its broad substrate promiscuity by hydrolyzing ester bonds linked to aliphatic groups. The three-dimensional structure of the enzyme was solved in the presence and absence of substrate (tributyrin), revealing its classification within the α/ß-hydrolase superfamily. Despite being a monomeric enzyme, enzymatic assays reveal a cooperative behavior with a sigmoidal profile (initial velocities vs substrate concentrations). Our investigation brings to light the allokairy/hysteresis behavior of Ade1, as evidenced by a transient burst profile during the hydrolysis of substrates such as p-nitrophenyl butyrate and p-nitrophenyl octanoate. Crystal structures of Ade1, coupled with molecular dynamics simulations, unveil the existence of multiple conformational structures within a single molecular state (E̅1). Notably, substrate binding induces a loop closure that traps the substrate in the catalytic site. Upon product release, the cap domain opens simultaneously with structural changes, transitioning the enzyme to a new molecular state (E̅2). This study advances our understanding of hysteresis/allokairy mechanisms, a temporal regulation that appears more pervasive than previously acknowledged and extends its presence to metabolic enzymes. These findings also hold potential implications for addressing human diseases associated with metabolic dysregulation.


Subject(s)
Esterases , Molecular Dynamics Simulation , Esterases/chemistry , Esterases/metabolism , Esterases/genetics , Substrate Specificity , Catalytic Domain , Crystallography, X-Ray , Protein Conformation , Hydrolysis , Kinetics , Models, Molecular
2.
J Gene Med ; 13(3): 148-57, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21344541

ABSTRACT

BACKGROUND: Metastatic renal cell carcinoma (mRCC) is one of the most treatment-resistant malignancies. Despite all new therapeutic advances, almost all patients develop resistance to treatment and cure is rarely seen. In the present study, we evaluated the antitumor effect of a bicistronic retrovirus vector encoding both endostatin (ES) and interleukin (IL)-2 using an orthotopic metastatic RCC mouse model. METHODS: Balb/C-bearing Renca cells were treated with NIH/3T3-LendIRES-IL-2-SN cells. In the survival studies, mice were monitored daily until they died. At the end of the in vivo experiment, serum levels of IL-2 and ES were measured, the lung was weighed, and the number of metastatic nodules, nodule area, tumor vessels and proliferation of tumor-infiltrating Renca cells were determined. RESULTS: Inoculation of NIH/3T3-LendIRES-IL-2-SN cells resulted in an increase in ES and IL-2 levels in the treated group (p < 0.05). There was a significant decrease in lung wet weight, lung nodule area and tumor vessels in the treated group compared to the control group (p < 0.001). The proliferation of Renca cells in the bicistronic-treated group was significantly reduced compared to the control group (p < 0.05). Kaplan-Meier survival curves showed that the probability of survival was significantly higher for mice submitted to bicistronic therapy (log-rank test, p = 0.0016). Bicistronic therapy caused an increase in the infiltration of CD4, CD4 interferon (IFN)γ-producing, CD8, CD8 IFNγ-producing and natural killer (CD49b) cells. CONCLUSIONS: Retroviral bicistronic gene transfer led to the secretion of functional ES and IL-2 that was sufficiently active to: (i) inhibit tumor angiogenesis and tumor cell proliferation and (ii) increase the infiltration of immune cells.


Subject(s)
Carcinoma, Renal Cell/therapy , Endostatins/genetics , Genetic Therapy , Interleukin-2/genetics , Kidney Neoplasms/therapy , Lung Neoplasms/secondary , Animals , Carcinoma, Renal Cell/blood supply , Carcinoma, Renal Cell/mortality , Carcinoma, Renal Cell/secondary , Cell Line , Cell Proliferation , Disease Models, Animal , Endostatins/blood , Endostatins/metabolism , Genetic Vectors/genetics , Humans , Interleukin-2/blood , Interleukin-2/metabolism , Kaplan-Meier Estimate , Kidney Neoplasms/blood supply , Kidney Neoplasms/mortality , Kidney Neoplasms/pathology , Lung Neoplasms/blood supply , Lung Neoplasms/mortality , Lung Neoplasms/therapy , Male , Mice , Mice, Inbred BALB C , Neovascularization, Pathologic/prevention & control , Random Allocation , Retroviridae/genetics , Tumor Burden
3.
Genet Mol Res ; 2(1): 124-35, 2003 Mar 31.
Article in English | MEDLINE | ID: mdl-12917809

ABSTRACT

The yeast two-hybrid system is a powerful tool for screening protein-protein interactions and has also been used for large-scale studies. We evaluated two protein-coding sequences as reporter genes for the yeast two-hybrid system, to determine if it was suitable as an alternative screening strategy. Aspergillus awamori glucoamylase activity results in clear haloes around colonies producing this enzyme after growth on starch plates and staining with iodine vapors. However, transcription activation by Gal4 on Gal-regulated promoters was insufficient for this type of phenotypic visualization. A modified gene of Aequoria victoria enhanced green fluorescent protein (EGFP) was tested to determine its suitability for interaction screenings with flow cytometry. When the EGFP reporter gene system was incorporated into the cells, Gal4 transcriptional activation produced sufficient fluorescence for detection with the flow cytometer, especially when there were strong interactions.


Subject(s)
Genes, Reporter , Two-Hybrid System Techniques , Yeasts/genetics , Base Sequence , Cloning, Molecular , Flow Cytometry , Glucan 1,4-alpha-Glucosidase/analysis , Glucan 1,4-alpha-Glucosidase/genetics , Green Fluorescent Proteins , Luminescent Proteins/analysis , Luminescent Proteins/genetics , Molecular Sequence Data , Sequence Alignment
4.
Ciênc. cult. (Säo Paulo) ; 45(3/4): 181-91, May-Aug. 1993. ilus, tab, graf
Article in English | LILACS | ID: lil-201865

ABSTRACT

The major microbial alcoholic fermenter, the yeast Saccharomyces cerevisiae, is unable to utilize starch for ethanol production because it lacks starch degrading enzymes. Yeast genetic engineering makes it possible to obtain strains expressing amylases from a variety of different organisms. Here we present a review of the main results obtained in our group pursuing a stable recombinant S. cerevisiae strain possessing all of the enzymatic activities needed for the production of ethanol from starchy raw materials.


Subject(s)
Amylases/metabolism , Ethanol , Saccharomyces cerevisiae/enzymology , Alcohol Industry , Fermentation
SELECTION OF CITATIONS
SEARCH DETAIL
...